Exact Sciences (EXAS) 'Major Overhang' Removed amid Competitor Data - Jefferies

December 16, 2022 8:23 AM EST Send to a Friend
Jefferies analyst Brandon Couillard reiterated a Buy rating and $70.00 price target on Exact Sciences (NASDAQ: EXAS) as a major ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login